Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
01/2008
01/03/2008WO2007023461A3 Method for detection of micro-organisms and antibiotic resistance markers and nucleic acid oligonucleotides therefor
01/03/2008WO2006116276A3 Real-time hpv pcr assays
01/03/2008WO2006069592A3 Method for diagnosing an/or predicting preeclampsia and/or related disorders
01/03/2008WO2006034321A3 Oligomeric compounds effecting drosha-mediated cleavage
01/03/2008WO2005118857A3 Methods and agents for screening for compounds capable of modulating vegf expression
01/03/2008WO2005079196A3 Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in prokaryotes
01/03/2008WO2005047505A3 Methods and products for expression of micro rnas
01/03/2008WO2005032476A3 Methods and compositions for cpg15-2
01/03/2008WO2005010166A3 P450 oxygenases and methods of use
01/03/2008WO2004081226A3 Carboxylic acid reductase polypeptide, nucleotide sequence encoding same and methods of use
01/03/2008WO2004060323A3 Novel inhibitors of poxvirus replication
01/03/2008WO2003095473A3 Peptides and methods for cell death regulation
01/03/2008US20080005813 Polypeptide Having Function of Cinnamyl Alcohol Dehydrogenase, Polynucleotide Encoding the Polypeptide and Those Uses
01/03/2008US20080005809 sequences from maize, soybean and Arabidopsis thaliana associated with transcription factors; genome mapping, gene identification and analysis, plant breeding, preparation of constructs for use in plant gene expression and transgenic plants
01/03/2008US20080004848 Direct to consumer genotype-based products and services
01/03/2008US20080004561 Method for Treating Oncological, Virulent and Somatic Diseases, Method for Controlling Treatment Efficiency, Pharmaceutical Agents and Composition for Carrying Out Said Treatment
01/03/2008US20080004437 Cloned Genes Encoding Reverse Transcriptase lacking RNase H Activity
01/03/2008US20080004355 Method for Inhibiting Telomerase Activity and an Agent for Inhibiting the Same
01/03/2008US20080004251 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor
01/03/2008US20080004243 Method for predicting susceptibility to radiation pneumonitis
01/03/2008US20080004233 Delta-Tocotrienol Treatment and Prevention of Pancreatic Cancer
01/03/2008US20080004232 Characterization of c19orf10, a Novel Synovial Protein
01/03/2008US20080004231 Disease-Associated Protein
01/03/2008US20080004230 SAM Riboswitch and Uses Thereof
01/03/2008US20080004229 Methods and Compositions Related to Skcg-1, a Tumor Suppressor
01/03/2008US20080004227 Pharmaceutical Composition for Lowering Blood Sugar Level
01/03/2008US20080004211 Inhibitors of Amyloid Fibril Formation and Uses Thereof
01/03/2008US20080004209 Incubating resistin with a cathepsin, in the presence of a test compound; and measuring the level of proteolyzed resistin
01/03/2008US20080004208 Methods for Diagnosis and Prognosis of Malignant Lymphoma
01/03/2008US20080003691 Method of Detecting Conformational Change of an Amyloid Protein, a Method of Searching a Substance Having an Activity that Affects to Conformational Change of an Amyloid Protein, and Method of Searching a Therapeutic or Diagnostic Agent for Amyloid-Related Diseases
01/03/2008US20080003675 Methods and compositions for identifying morphogen analogs
01/03/2008US20080003638 Multicompartment apparatus for monitoring, evaluating and measuring concentration of microorganisms in fluids; mulltiplex detection; article for holding a liquefied sample for the quantification
01/03/2008US20080003637 Methods for Separating Hepatic, Endothelial, or Hematopoietic Progenitor Cells From Cell Populations
01/03/2008US20080003636 Method for detecting pathogenic microorganism and antimicrobial agent, method for evaluating effect of antimicrobial agent, and antimicrobial agent
01/03/2008US20080003635 High Throughput Collagen Synthesis Assay
01/03/2008US20080003634 Extended Primary Retinal Cell Culture and Stress Models, and Methods of Use
01/03/2008US20080003633 Methods for Relieving Neuropathic Pain by Modulating Alpha1G T-Type Calcium Channels and Mice Lacking Alpha 1G T-Type Calcium Channels
01/03/2008US20080003631 Methods and materials for in vitro analysis and/or use of membrane-associated proteins, portions thereof or variants thereof
01/03/2008US20080003630 Tyrosine kinse substrate
01/03/2008US20080003629 Device and method for detection of vitamins and nutritional minerals
01/03/2008US20080003628 Method for enhancing stability of a composition comprising soluble glucose dehydrogenase (gdh)
01/03/2008US20080003627 System for biosynthesis of firefly luminescence substrate with natural l-cysteine or derivatives thereof and luminescence substrate solutions containing the system
01/03/2008US20080003624 Cancer metastasis determination method
01/03/2008US20080003618 Methods of identifying compounds that modulate il-4 receptor-mediated ige synthesis utilizing a b-cell associated protein
01/03/2008US20080003611 Heat lysis production of proteins
01/03/2008US20080003610 Method for identifying germs
01/03/2008US20080003609 Method of detecting bladder urothelial carcinoma
01/03/2008US20080003608 Highly Specific Polyclonal Antibodies of Individual Core Histone and Uses Thereof
01/03/2008US20080003607 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions
01/03/2008US20080003606 Diagnosis of tamoxifen sensitivity
01/03/2008US20080003605 Microarray analysis of light chain variable gene expression and methods of use
01/03/2008US20080003604 Methods, compositions, and kits for detecting protein aggregates
01/03/2008US20080003603 Human melanoma mutation
01/03/2008US20080003602 Ligation-Based Rna Amplification
01/03/2008US20080003601 Detection of nucleic acid differences using combined endonuclease cleavage and ligation reactions
01/03/2008US20080003600 Isothermal screening of breast cancer related nucleic acid
01/03/2008US20080003599 Biological Microchip for Multiple Parallel Immunoassay of Compounds and Immunoassay Metods Using Said Microchip
01/03/2008US20080003598 Association of gene expression and psychiatric disoders
01/03/2008US20080003597 Multidimensional organization of heteromolecules by robust dna motifs
01/03/2008US20080003596 Vector and method for detecting the change in transcription amount
01/03/2008US20080003595 Methods for microorganism detection and identification
01/03/2008US20080003594 Systems and methods for monitoring the amplification and dissociation behavior of DNA molecules
01/03/2008US20080003593 System and methods for monitoring the amplification and dissociation behavior of DNA molecules
01/03/2008US20080003592 Method for conducting pharmacogenomics-based studies
01/03/2008US20080003591 Neisseria Gonorrhoeae Detection Using the 5' Untranslated Region of the Opa Gene
01/03/2008US20080003590 Termination of Binding Parameters
01/03/2008US20080003589 Method of measuring repeat number of unit base
01/03/2008US20080003588 Real-time PCR in micro-channels
01/03/2008US20080003587 Controllably flowing a solution of nucleic acid over a first substrate to promote stretching and transferring the stretched molecule to a second substrate
01/03/2008US20080003586 Controllably flowing a solution of nucleic acid over a first substrate to promote stretching and transferring the stretched molecule to a second substrate
01/03/2008US20080003585 Purification and amplification of nucleic acids in a microfluidic device
01/03/2008US20080003584 sequentially providing two or more charged tRNA during in vitro protein synthesis; directed protein evolution
01/03/2008US20080003583 Apparatus for arbitrary peptide synthesis
01/03/2008US20080003582 Sequentially providing two or more charged tRNA during in vitro protein synthesis; directed protein evolution
01/03/2008US20080003581 Sequentially providing two or more charged tRNA during in vitro protein synthesis; directed protein evolution
01/03/2008US20080003580 sequentially providing two or more charged tRNA during in vitro protein synthesis; directed protein evolution
01/03/2008US20080003579 for sequentially providing two or more charged tRNA during in vitro protein synthesis; directed protein evolution
01/03/2008US20080003578 Apparatus for arbitrary peptide synthesis
01/03/2008US20080003577 Methods for arbitrary peptide synthesis
01/03/2008US20080003576 Assay platforms and detection methodology using surface enhanced Raman scattering (SERS) upon specific biochemical interactions
01/03/2008US20080003575 Methods and composition for RNA extraction
01/03/2008US20080003574 Kits for RNA extraction
01/03/2008US20080003573 Determination of variants produced upon replication or transcription of nucleic acid sequences
01/03/2008US20080003572 for performing surface assays comprising a capillary pump containing at least two zones having different capillary pressures for obtaining controlled flow rate of liquids
01/03/2008US20080003571 Reagents, methods, and libraries for bead-based sequencing
01/03/2008US20080003570 Translation enhancer elements of genes encoding human Tau protein and human alpha-synuclein protein
01/03/2008US20080003569 Method for the Detection of Intracellular Parameters With Luminescent Protein Probes for the Screening of Molecules Capable of Altering Said Parameters
01/03/2008US20080003568 Method for Enriching and/or Separating Prokaryotic Dna Using a Protein that Specifically Bonds to Unmethylated Dna Containing Cpg-Motives
01/03/2008US20080003567 Use of Lunasin Peptide as a Transcriptional Activator to Prevent Cancer and Related Methods for Treatment, Monitoring and Prognosis
01/03/2008US20080003566 Molecular Analysis
01/03/2008US20080003565 Viral nucleic acid microarray and method of use
01/03/2008US20080003564 Sample processing
01/03/2008US20080003563 Method for Manufacturing Specific Binding Molecules Against Selected Target Molecules, Kit, and Binding Molecules
01/03/2008US20080003562 Counting biological agents on biological growth plates
01/03/2008US20080003240 Contacting sample of cell that contains exogenous FGFR3 where contacted cell is capable of BoNT/A intoxication and detecting presence of BoNT/A activity of cell relative to control cell, where difference in BoNT/A activity of contacted cell compared to control cell is indicative of BoNT/A activity
01/03/2008US20080003227 Acetyl CoA Carboxylase Splice Variant and Uses Thereof
01/03/2008US20080003223 Babesia canis vaccine
01/03/2008US20080003222 Inhibitors for L1 and Adam10 for the Treatment of Carcinomas
01/03/2008US20080003199 IL-33 in the treatment and diagnosis of diseases and disorders
01/03/2008US20080003190 Antibacterial botanicals